Funding Rounds
TILT Biotherapeutics

TILT Biotherapeutics Series A (2023, $10M)

TILT Biotherapeutics

Cancer immunotherapy researcher.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $10.61M

Raised Date: 2023-07-01

Investors